Back to MORGAN STANLEY MORGAN STANLEY

NVCRNVCR
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in NOVOCURE LTD

MORGAN STANLEY holds 4.5M shares of NVCR (NOVOCURE LTD), worth $68.5M as of 2026-Q2. The position was decreased (-0.4% shares). NVCR represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$68.5M

Current Shares

4.5M

Total Value Change

+$54.7M

Total Shares Change

+3.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
4.5M
-0.4%
$68.5M0.0%$15.15
0
2026-Q1
Decreased
4.5M
-10.4%
$49.5M0.0%$13.30
0
2025-Q4
Increased
5.1M
+453.4%
$65.6M0.0%$13.22
48
2025-Q3
Increased
916,154
+25.2%
$11.8M0.0%$12.92
34
2025-Q2
Increased
731,629
+19.7%
$13M0.0%$18.00
33
2025-Q1
Increased
610,996
+0.5%
$10.9M0.0%$18.86
28
2024-Q4
Decreased
608,126
-9.3%
$18.1M0.0%$30.08
0
2024-Q3
Decreased
670,121
-16.9%
$10.5M0.0%$15.61
0
2024-Q2
New
806,524
-
$13.8M0.0%$17.13
39

Other major holders of NVCR: BNP PARIBAS FINANCIAL MARKETS, Capital World Investors, BAILLIE GIFFORD & CO, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used